Team

  • Taro Inaba / Managing Partner

    Taro-small
    Taro has over 25 years of business development and venture investment experience. He spent 13 years at Mitsui Ventures in the venture investment field during which time he led the deal discovery, negotiation and due diligence process for the major portfolio companies in the drug discovery and development area and held positions as a board member in 11 companies. While at Mitsui Ventures he built and managed the biopharma investment team and infrastructure and served as President & CEO from 2008 to 2009. Prior to Mitsui Ventures Taro spent 10 years in various capacities at Mitsui & Co. Ltd, including extensive experience in business development roles. Taro holds a B.E. in Polymer Chemistry, Kyoto University and MBA from European University. Taro is a CFA charter holder.
  • Walter Olesiak / Partner

    Walter-small
    Walter has over 24 years experience in business development, healthcare consulting and venture investment. Walter spent 8 years in venture investments with Mitsui Ventures, during which time he held positions as a board member or observer in 10 portfolio companies. Prior to Mitsui Walter spent 6 years with Cambridge Pharma Consultancy (an IMS Health company) advising on global pharmaceutical pricing, reimbursement and market access issues to leading pharmaceutical and biotechnology companies. Prior to Cambridge, Walter spent 8 years in Tokyo in various roles with Genzyme Japan and SRL, Inc. Walter holds a AB in Biochemical Sciences from Harvard University and MBA from Cornell University.
  • Takaaki Tobaru / Partner

    Aki Tobaru
    Aki has more than 20 years of experience in search and evaluation, business development and venture investment. Prior to joining Remiges, he was at Ora as Vice President of Corporate Development with focusing on identifying innovative opportunities for licensing, Joint Venture and new corporate formation. Aki worked at Daiichi-Sankyo for more than 13 years with focusing on identifying opportunities from discovery to late clinical stage. He played an important role in establishing and managing Sankyo’s Corporate Venture Capital funds. Aki helps several privately-held companies in the US/EU with fund raising and BD activities. Aki holds a BSc. in Material Sciences from Tokyo University of Agriculture and Technology, and MSc. from San Diego State University. He also holds M.B.A. from the University of California, San Diego.
  • Stephen Gitto / Director of Finance

    Stephen-small
    Stephen is a Certified Public Accountant licensed in New York with more than 35 years experience in banking, real estate and venture capital. He spent 12 years with Mitsui Global Investments as General Manager of Administration. Prior to Mitsui Stephen spent 7 years with Soros Fund Management as CFO of various investment funds including real estate, mezzanine loans and private equity. Stephen is currently an adjunct assistant professor of accounting at the City University of New York.
  • Tomoyuki Hirata / Venture Partner

    Tomoyuki-small
    Tomoyuki has worked at Sumitomo Dainippon Pharma for 12 years. He has 10 years experience in drug discovery programs in fields such as hyperlipidemia, diabetes, hypertension and muscular diseasecachexia. Tomoyuki worked for two years in the group responsible for the establishment of an iPSC-based drug discovery platforms. In December 2014, he joined the group focused on in-licensing of early stage assets. Since April 2015, he has been with Remiges Ventures as a secondee from Sumitomo Dainippon Pharma. Tomoyuki is particularly interested in investment and collaboration opportunities related to neurodegenerative and neurodevelopmental diseases, and other diseases with high unmet medical need. Tomoyuki earned his Ph.D. at the Department of Biological Sciences, Graduate School of Science, Osaka University in 2003.
  • Fumitaka Mori / Venture Partner

    Fumitaka-small
    Fumitaka has 12 years of drug discovery, strategic research planning and portfolio strategy experience. He is a secondee from Taiho Pharmaceutical. While at Taiho his responsibilities included drug discovery research, research planning, research alliance and portfolio strategy. Fumitaka holds a MSc in Life Science from the University of Hyogo and a Ph.D. in Clinical Pharmaceutical Sciences from the University of Shizuoka.
  • Hitoshi Ono / Venture Partner

    Hitoshi-small
    Hitoshi is a secondee from Taiho Pharmaceutical with 9 years experience in planning and management of clinical trial. For the first four years, he belonged to Science Planning Section. For the next five years, he belonged to Medical Affairs department. Hitoshi holds a MSc. in protein engineering and Management of Technology (MOT) from Okayama University.
  • Linda Li / Venture Partner

    Linda-small
    Linda has business development and investment experience. She has served as Assistant Project Manager at Boston Biomedical, Manager of Corporate Development & Strategy at 1Globe Health Institute, and Vice President at 1Globe Capital. Linda holds an AB in Economics with high honors from Princeton University.